Standard BioTools Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Standard BioTools Inc. (LAB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 18.00 thousand shares for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2013-11-07
- Standard BioTools Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2013-09-30 was 18.00K shares, a 60.00% decline year-over-year.
- Standard BioTools Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2013-06-30 was 118.00K shares, a 7.27% increase year-over-year.
- Standard BioTools Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2013-03-31 was 1.09M shares.
- Standard BioTools Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2012-09-30 was 45.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month |
|---|---|---|---|
| 2013-09-30 | 18.00K shares 10-Q · filed 2013-11-07 | 136.00K shares derived: sum of 2 quarters · filed 2013-11-07 | 1.23M shares 10-Q · filed 2013-11-07 |
| 2013-06-30 | 118.00K shares 10-Q · filed 2013-08-07 | 1.21M shares 10-Q · filed 2013-08-07 | |
| 2013-03-31 | 1.09M shares 10-Q · filed 2013-05-09 | ||
| 2012-09-30 | 45.00K shares 10-Q · filed 2012-11-09 | 155.00K shares derived: sum of 2 quarters · filed 2012-11-09 | 1.03M shares 10-Q · filed 2012-11-09 |
| 2012-06-30 | 110.00K shares 10-Q · filed 2012-08-14 | 988.00K shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |